Abstract
The aim of the current study was to determine the degree to which patients with panic disorder develop tolerance to subjective and physiological effects of benzodiazepine after chronic treatment with alprazolam. Response to acute administration of diazepam was assessed in 19 panic disorder patients receiving chronic treatment with alprazolam and 23 untreated panic disorder patients. At baseline in the laboratory, the two groups did not differ in peak saccadic eye movement velocity, saccade latency, short-term memory, plasma cortisol and growth hormone concentrations, heart rate, and self-rated levels of sedation and anxiety. Compared with untreated patients, alprazolam-treated patients displayed significantly less diazepam-induced change in peak saccadic velocity, saccade latency, growth hormone secretion, memory, and self-rated levels of sedation. There was no difference between groups in diazepam effects on plasma cortisol concentrations or self-rated anxiety. Within alprazolam-treated patients, diazepam-induced slowing of peak saccade velocity was significantly inversely correlated with illness severity, as measured by reported panic attacks per week and severity of phobic avoidance, but not with alprazolam dose, blood level, or duration of treatment. Because the alprazolam-treated group reported more panic attacks per week than the untreated panic patients, treated patients were divided into those who were asymptomatic versus those with continuing panic attacks. The subgroup of nine alprazolam-treated subjects who were asymptomatic also showed significantly less diazepam effects than the group of untreated panic disorder patients, suggesting that overall group differences were at least partially attributable to the development of tolerance to selected benzodiazepine effects with chronic alprazolam treatment.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
This work was supported by NIH grants MH43449, MH49413, and AA08161.
Rights and permissions
About this article
Cite this article
Cowley, D., Roy-Byrne, P., Radant, A. et al. Benzodiazepine Sensitivity in Panic Disorder: Effects of Chronic Alprazolam Treatment. Neuropsychopharmacol 12, 147–157 (1995). https://doi.org/10.1016/0893-133X(94)00074-A
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/0893-133X(94)00074-A
Keywords
This article is cited by
-
Tolerance and dependence following chronic alprazolam treatment: quantitative observation studies in female rhesus monkeys
Psychopharmacology (2020)
-
The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal
Psychopharmacology (2007)
-
Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder
Psychopharmacology (2005)
-
Interdose Elevation in Plasma Cortisol During Chronic Treatment with Alprazolam but not Lorazepam in the Elderly
Neuropsychopharmacology (2004)
-
Common effects of chronically administered antipanic drugs on brainstem GABAA receptor subunit gene expression
Molecular Psychiatry (2001)